NicOx Articles
NicOx takes option to buy UK ophthalmic company
22 March 2012
NicOx earns $10M milestone under Bausch & Lomb accord
13 March 2012
NicOx says it is “well funded” and has robust pipeline, despite recent disappointment with naproxcinod
20 May 2010
Disappointments for NicOx, as FDA panel rejects naproxcinod, and GlaxoSmithKline, which halts Promacta trial
13 May 2010
Showing 1-6 of 6 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
